Comparing AI and traditional methods for analyzing pancreatic lesions
Official title: Artificial Intelligence for Rapid On-site Evaluation (AI-ROSE) for Endoscopic Ultrasound-guided Fine-needle Aspiration (EUS-FNA) Biopsy of Pancreatic Solid Lesions: A Prospective Double Blinded Study
Run by The University of Texas Health Science Center, Houston · NCT05018663 · Data updated 2026-11-12
This study is testing if using artificial intelligence to analyze pancreatic tissue samples can give accurate results compared to having a doctor look at them right away.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | July 21, 2021 |
| Main results expected | July 31, 2024 |
| Study ends | January 30, 2028 |
| Registry record updated | February 16, 2023 |
| Trial ID | NCT05018663 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with endoscopic ultrasound findings of pancreatic solid lesions who can safely undergo FNA or FNB.
✕Probably not a fit
Patients who cannot provide informed consent or have contraindications for FNA/FNB will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the effectiveness of artificial intelligence (AI) in interpreting samples obtained from endoscopic ultrasound-guided fine needle aspiration (FNA) and biopsy (FNB) of pancreatic solid lesions. It will compare the adequacy of sample interpretation between real-time on-site evaluation (ROSE) by a cytopathologist and AI analysis at the bedside. Patients will undergo standard procedures for sample collection, with slides being prepared for both human and AI analysis. The study seeks to determine the accuracy of preliminary diagnoses made using these two methods against final pathology reports.
Why it matters
Potential benefit: If successful, this study could enhance the accuracy and efficiency of diagnosing pancreatic lesions, leading to better patient outcomes.
How similar studies have gone: While the use of AI in cytopathology is an emerging field, this specific comparison of AI and ROSE in pancreatic lesions is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have EUS finding of a PSL; * Do not have contraindications for FNA/FNB. Exclusion Criteria: * Inability to provide informed consent for the procedure; * Contraindication for FNA/FNB eg coagulopathy, lack of avascular window for FNA.
Where it's running
-
Memorial Hermann Hospital
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Nirav Thosani, MD, MHA — The University of Texas Health Science Center, Houston
- Study coordinator: Prithvi B Patil, MS
- Email: prithvi.b.patil@uth.tmc.edu
- Phone: 7135006456
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Circadian Variation of Anti-Factor Xa in Trauma Patients on LMWH
This study tests whether anti-Factor Xa levels show a daily rhythm in hospitalized trauma patients receiving LMWH for VTE prevention.
-
PrioritiesAI: A chat tool to help older adults with hernia decide what matters most for surgery
This study tests an AI-powered chat assistant to help people with hernia clearly express and communicate their health goals for elective surgery.
-
Family-based program to reduce risk factors for schizophrenia spectrum disorders in youth with family history
This study tests a brief family-based psychosocial program to see if it lowers persistent psychotic-like experiences in kids and young adults with a family history of SSD and different brain risk patterns.
-
EUS-Guided RFA for Pancreatic Lesions: Safety and Outcomes
This study tests whether using endoscopic ultrasound-guided radiofrequency ablation is safe and helps patients with pancreatic lesions.
-
Skin-to-skin care with the Skincubator for preterm infants
This study tests whether using the Skincubator during skin-to-skin care is safe and feasible for preterm babies and their parents in the NICU.
-
See if iCHAMPSS 2.0 helps schools spread effective sexual health programs
This study tests whether iCHAMPSS 2.0 helps Texas schools implement an evidence-based sexual health program more effectively for teachers, administrators, and health staff.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.